Revolution Medicines Statistics
Total Valuation
RVMD has a market cap or net worth of $6.17 billion. The enterprise value is $4.55 billion.
| Market Cap | 6.17B |
| Enterprise Value | 4.55B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RVMD has 164.99 million shares outstanding. The number of shares has increased by 73.71% in one year.
| Shares Outstanding | 164.99M |
| Shares Change (YoY) | +73.71% |
| Shares Change (QoQ) | +45.58% |
| Owned by Insiders (%) | 2.39% |
| Owned by Institutions (%) | 98.79% |
| Float | 161.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,350.67 |
| Forward PS | 738.76 |
| PB Ratio | 3.57 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 996.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.45, with a Debt / Equity ratio of 0.05.
| Current Ratio | 18.45 |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,608.89 |
Financial Efficiency
Return on equity (ROE) is -36.40% and return on invested capital (ROIC) is -30.49%.
| Return on Equity (ROE) | -36.40% |
| Return on Assets (ROA) | -32.10% |
| Return on Capital (ROIC) | -30.49% |
| Revenue Per Employee | $12,079 |
| Profits Per Employee | -$1.28M |
| Employee Count | 378 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.52M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.32% in the last 52 weeks. The beta is 1.45, so RVMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | +39.32% |
| 50-Day Moving Average | 38.43 |
| 200-Day Moving Average | 30.40 |
| Relative Strength Index (RSI) | 42.66 |
| Average Volume (20 Days) | 1,338,587 |
Short Selling Information
The latest short interest is 15.52 million, so 9.41% of the outstanding shares have been sold short.
| Short Interest | 15.52M |
| Short Previous Month | 14.81M |
| Short % of Shares Out | 9.41% |
| Short % of Float | 9.64% |
| Short Ratio (days to cover) | 13.50 |
Income Statement
In the last 12 months, RVMD had revenue of $4.57 million and -$484.27 million in losses. Loss per share was -$3.82.
| Revenue | 4.57M |
| Gross Profit | 4.57M |
| Operating Income | -552.89M |
| Pretax Income | -487.80M |
| Net Income | -484.27M |
| EBITDA | -477.95M |
| EBIT | -487.49M |
| Loss Per Share | -$3.82 |
Balance Sheet
The company has $1.71 billion in cash and $88.03 million in debt, giving a net cash position of $1.62 billion or $9.81 per share.
| Cash & Cash Equivalents | 1.71B |
| Total Debt | 88.03M |
| Net Cash | 1.62B |
| Net Cash Per Share | $9.81 |
| Equity (Book Value) | 1.73B |
| Book Value Per Share | 10.46 |
| Working Capital | 1.64B |
Cash Flow
In the last 12 months, operating cash flow was -$448.74 million and capital expenditures -$9.14 million, giving a free cash flow of -$457.88 million.
| Operating Cash Flow | -448.74M |
| Capital Expenditures | -9.14M |
| Free Cash Flow | -457.88M |
| FCF Per Share | -$2.78 |
Margins
Gross margin is 100.00%, with operating and profit margins of -12,108.78% and -10,606.04%.
| Gross Margin | 100.00% |
| Operating Margin | -12,108.78% |
| Pretax Margin | -10,683.22% |
| Profit Margin | -10,606.04% |
| EBITDA Margin | -10,467.67% |
| EBIT Margin | -10,676.59% |
| FCF Margin | -10,028.01% |
Dividends & Yields
RVMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -73.71% |
| Shareholder Yield | -73.71% |
| Earnings Yield | -7.85% |
| FCF Yield | -7.42% |
Analyst Forecast
The average price target for RVMD is $42.00, which is 12.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $42.00 |
| Price Target Difference | 12.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 120.40% |
| EPS Growth Forecast (5Y) | -58.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RVMD has an Altman Z-Score of 19.5 and a Piotroski F-Score of 2.
| Altman Z-Score | 19.5 |
| Piotroski F-Score | 2 |